Bayer Stock Forecast for 2023 - 2025 - 2030

Updated on 02/01/2023

Stock Rating
7
Price Target
75.50€
Consensus
Outperform
Upside
32.46%
Analysts
12
Stock Rating
7
Upside
32.46%
Analysts
12
Price Target
75.50€

Bayer Stock Forecast and Price Target

According to twelve esteemed experts, the average price target for Bayer to reach this year is 75.50€, with a potential upside of approximately 32.46%. This prediction is based on a high estimate of 106.00€ and a low estimate of 54.00€. If you want to invest in BAYN stock, you might also want to take a look at how its competitors are doing.

75.50€

32.46% Upside

Outperform
Outperform

Bayer Fair Value Forecast for 2023 - 2025 - 2030

In the last two years, Bayer's Price has grown by 1.72%, rising from 53.25€ to 54.16€. For next year, analysts predict Fair Value of 67.48€, which would mean an increase of 24.58%. Over the next eight years, experts predict that Bayer's Fair Value will grow at a rate of 2.76%.

2023 Fair Value Forecast
67.48€
2024 Fair Value Forecast
70.89€
2025 Fair Value Forecast
73.88€
2026 Fair Value Forecast
71.64€
2027 Fair Value Forecast
60.32€
2028 Fair Value Forecast
57.74€
2029 Fair Value Forecast
56.33€
2030 Fair Value Forecast
55.66€
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ABBV Stock Forecast AbbVie Outperform 10
$147.74 Buy/Sell $162.12 11.68%
AZN Stock Forecast AstraZeneca PLC Outperform 8
£10.59k Buy/Sell £153.20 -98.53%
COST Stock Forecast Costco Wholesale Corp Outperform 13
$511.23 Buy/Sell $550.07 7.09%
DHR Stock Forecast Danaher Corp Outperform 10
$264.38 Buy/Sell $304.24 15.18%
ABT Stock Forecast Abbott Laboratories Outperform 10
$110.55 Buy/Sell $116.63 13.07%

Bayer Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Bayer's Revenue has grown by 1.23%, rising from 43.55€B to 44.08€B. For next year, analysts predict Revenue of 49.37€B, which would mean an increase of 12.00%. Over the next eight years, experts predict that Bayer's Revenue will grow at a rate of 16.35%.

2023 Rev Forecast
49.37€B
2024 Rev Forecast
50.31€B
2025 Rev Forecast
50.64€B
2026 Rev Forecast
50.39€B
2027 Rev Forecast
50.17€B
2028 Rev Forecast
50.09€B
2029 Rev Forecast
50.75€B
2030 Rev Forecast
51.29€B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
AMGN Stock Forecast Amgen Inc Hold 7
$271.73 Buy/Sell $268.00 2.31%
CSL Stock Forecast CSL Outperform 8
$301.85 Buy/Sell $218.60 -25.11%
BDX Stock Forecast Becton, Dickinson and Outperform 17
$252.22 Buy/Sell $268.00 9.03%

Bayer Dividend per Share Forecast for 2023 - 2025 - 2030

In the last two years, Bayer's Dividend per Share has decreased by 28.57%, going from 2.80€ to 2.00€. For next year, analysts predict Dividend per Share of 2.45€, which would mean an increase of 22.50%. Over the next eight years, experts predict that Bayer's Dividend per Share will grow at a rate of 20.00%.

2023 DPS Forecast
2.45€
2024 DPS Forecast
2.54€
2025 DPS Forecast
2.83€
2026 DPS Forecast
2.40€
2027 DPS Forecast
2.40€
2028 DPS Forecast
2.40€
2029 DPS Forecast
2.40€
2030 DPS Forecast
2.40€
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
GSK Stock Forecast GSK Hold 16
£1.42k Buy/Sell £16.95 -98.87%
CL Stock Forecast Colgate-Palmolive Co Outperform 18
$74.53 Buy/Sell $81.35 10.02%
BAS Stock Forecast BASF Hold 11
52.40€ Buy/Sell 53.50€ 4.96%

Bayer Free Cash Flow Forecast for 2023 - 2025 - 2030

Bayer's Free Cash Flow has decreased by 55.41% In the last two years, from 5.56€B to 2.48€B. In the next year, analysts believe that Free Cash Flow will reach 5.59€B – an increase of 125.74%. For the next eight years, experts predict that Bayer's Free Cash Flow will grow at a rate of 122.32%.

2023 FCF Forecast
5.59€B
2024 FCF Forecast
6.35€B
2025 FCF Forecast
7.46€B
2026 FCF Forecast
7.32€B
2027 FCF Forecast
6.17€B
2028 FCF Forecast
5.73€B
2029 FCF Forecast
5.62€B
2030 FCF Forecast
5.51€B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
CTVA Stock Forecast Corteva Outperform 12
$64.44 Buy/Sell $73.12 13.28%
DOW Stock Forecast Dow Hold 11
$59.35 Buy/Sell $54.73 -8.17%
DD Stock Forecast DuPont de Nemours Outperform 17
$73.95 Buy/Sell $80.00 8.18%

Bayer Net Income Forecast for 2023 - 2025 - 2030

In the last two years, Bayer's Net Income has decreased from 4.09€B to 1000.00€M – a 75.56% drop. In the next year, analysts believe that Net Income will reach 7.93€B – an increase of 692.94%. For the next eight years, the forecast is for Net Income to grow by 557.30%.

2023 NI Forecast
7.93€B
2024 NI Forecast
8.36€B
2025 NI Forecast
8.42€B
2026 NI Forecast
7.44€B
2027 NI Forecast
7.12€B
2028 NI Forecast
6.82€B
2029 NI Forecast
6.64€B
2030 NI Forecast
6.57€B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
SGO Stock Forecast Compagnie de Saint-Gobain Outperform 18
52.38€ Buy/Sell 71.19€ 40.32%
GIVN Stock Forecast Givaudan Hold 18
CHF2.93k Buy/Sell CHF4.11k 4.06%
GMAB Stock Forecast Genmab A/S Outperform 16
kr3.00k Buy/Sell kr2.84k -8.24%

Bayer EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, Bayer's EBITDA has decreased from 10.81€B to 8.42€B – a 22.08% drop! In the next year, analysts believe that EBITDA will reach 13.29€B – an increase of 57.78%. For the next eight years, the forecast is for EBITDA to grow by 79.91%.

2023 EBITDA Forecast
13.29€B
2024 EBITDA Forecast
13.61€B
2025 EBITDA Forecast
13.65€B
2026 EBITDA Forecast
12.12€B
2027 EBITDA Forecast
14.47€B
2028 EBITDA Forecast
14.44€B
2029 EBITDA Forecast
14.77€B
2030 EBITDA Forecast
15.15€B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ALNY Stock Forecast Alnylam Pharmaceuticals Outperform 7
$226.40 Buy/Sell $244.18 10.87%
4503 Stock Forecast Astellas Pharma Outperform 18
¥1.92k Buy/Sell ¥0.00 24.74%
BEI Stock Forecast Beiersdorf Outperform 17
111.60€ Buy/Sell 110.36€ 3.05%

Bayer EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Bayer's EBIT has grown by 2.46%, rising from 6.98€B to 7.15€B. For the next year, analysts predict that EBIT will reach 8.95€B – an increase of 25.09%. Over the next eight years, experts believe that Bayer's EBIT will grow at a rate of 54.24%.

2023 EBIT Forecast
8.95€B
2024 EBIT Forecast
9.30€B
2025 EBIT Forecast
10.02€B
2026 EBIT Forecast
8.86€B
2027 EBIT Forecast
12.64€B
2028 EBIT Forecast
10.33€B
2029 EBIT Forecast
10.65€B
2030 EBIT Forecast
11.03€B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BAX Stock Forecast Baxter International Outperform 17
$45.69 Buy/Sell $62.83 26.94%
1301 Stock Forecast Formosa Plastics Outperform 18
NT$88.60 Buy/Sell NT$125.45 49.55%
4523 Stock Forecast Eisai Hold 18
¥8.15k Buy/Sell ¥0.00 -18.99%

Bayer EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last two years, Bayer's EPS has grown by 1.72%, rising from 6.40€ to 6.51€. For next year, analysts predict EPS of 8.11€, which would mean an increase of 24.58%. Over the next eight years, experts predict that Bayer's EPS will grow at a rate of 2.76%.

2023 EPS Forecast
8.11€
2024 EPS Forecast
8.52€
2025 EPS Forecast
8.88€
2026 EPS Forecast
8.61€
2027 EPS Forecast
7.25€
2028 EPS Forecast
6.94€
2029 EPS Forecast
6.77€
2030 EPS Forecast
6.69€
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
CHD Stock Forecast Church & Dwight Co Inc Hold 11
$80.87 Buy/Sell $82.17 5.11%
AKZA Stock Forecast Akzo Nobel N.V. Outperform 18
65.30€ Buy/Sell 113.10€ 66.16%
BIM Stock Forecast bioMérieux Outperform 18
96.70€ Buy/Sell 105.55€ 11.17%